http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107865869-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0d44338a9983e0302c286cb9d319ff9 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-4866 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-439 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P39-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20 |
| filingDate | 2016-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_685253980351b754f8ecf6867157fabf |
| publicationDate | 2018-04-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-107865869-A |
| titleOfInvention | Applications of the Daphenylline in anti-anoxic medicine is prepared |
| abstract | The invention discloses applications of the Daphenylline in anti-anoxic medicine is prepared.The present invention passes through entirety and cellular level anoxia model; observe Daphenylline oxygen lack resistant function; as a result show that Daphenylline is remarkably improved survival rate and the time-to-live of asphyxia anoxia and acute decompression hypoxia mouse; mitigate the myocardial damage of drug specificity hypoxia mice; neonatal rat myocardial cell and nerve cell anoxia-induced apoptosis in vitro culture also have significant protective effect, there is provided purposes of the Daphenylline in anti-anoxic medicine is prepared. |
| priorityDate | 2016-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.